This content is from:www.yabo88.com Oxford University Has a Shot at Vaccine Billions. Or Does It? Inside the competitive, turbulent, and morally fraught race to capitalize on a Covid-19 vaccine. ByAmy Whyte September 23, 2020
This content is from:365亚博 The Morning Brief: Starboard Raises Stake in Drugmaker Perrigo ByStephen Taub November 16, 2016
This content is from:Premium 对冲基金巨头赌大制药商夏尔的往下cess John Paulson, Dan Loeb, and other prominent Investors move into an industry in flux. ByBailey McCann December 08, 2016
This content is from:365亚博 The Morning Brief: Valeant Shares Resume Their Free-Fall Shares of the drugmaker owned by ValueAct and dumped by Pershing Square closed at less than nine bucks apiece on Tuesday. ByStephen Taub April 19, 2017
This content is from:Premium Jeffrey Ubben’s ValueAct Continues to Surge Despite its Valeant Stake The activist firm’s flagship hedge fund is still up for the year despite still holding shares of the embattled drugmaker. ByStephen Taub July 14, 2017
This content is from:亚慱体育app怎么下载 ‘They’d Find Fraud, Fraud, Fraud.’ A small group of short sellers, spurned investors, a former journalist, and an ex-prosecutor are intent on revealing large-scale fraud in China. ByMichael Rapoport July 22, 2020
